TY - JOUR
KW - Public Health, Environmental and Occupational Health
KW - Parasitology
KW - Infectious Diseases
KW - General Medicine
KW - Neglected tropical diseases (NTDs)
AU - Molyneux DH
AU - Asamoa-Bah A
AU - Fenwick A
AU - Savioli L
AU - Hotez P
AB - Abstract
The history of the neglected tropical disease movement is seen through the lens of authors who worked during the last 4 decades in different roles and in different settings, from Western-based laboratories to clinical roles in endemic countries and in critical policy roles in the World Health Organization (WHO). The authors seek to identify key players from the introduction of the word ‘neglected’ by the late Kenneth Warren in his Rockefeller Foundation–supported Great Neglected Diseases of Mankind movement through to the more recent developments after the London Declaration of 2012. The role of the various actors—endemic countries, major pharmaceutical companies, the WHO, non-government development organizations, bilateral donors and academia—are discussed. The critical events and decisions are highlighted that were essential enabling factors in creating a viable and successful movement and with a resultant massive global public health and antipoverty impact. The importance of advocacy is emphasized in creating the momentum to establish a globally recognized public health ‘brand’ as a target in the United Nations Sustainable Development Goals.
BT - Transactions of The Royal Society of Tropical Medicine and Hygiene
DO - 10.1093/trstmh/trab015
IS - 2
LA - eng
N2 - Abstract
The history of the neglected tropical disease movement is seen through the lens of authors who worked during the last 4 decades in different roles and in different settings, from Western-based laboratories to clinical roles in endemic countries and in critical policy roles in the World Health Organization (WHO). The authors seek to identify key players from the introduction of the word ‘neglected’ by the late Kenneth Warren in his Rockefeller Foundation–supported Great Neglected Diseases of Mankind movement through to the more recent developments after the London Declaration of 2012. The role of the various actors—endemic countries, major pharmaceutical companies, the WHO, non-government development organizations, bilateral donors and academia—are discussed. The critical events and decisions are highlighted that were essential enabling factors in creating a viable and successful movement and with a resultant massive global public health and antipoverty impact. The importance of advocacy is emphasized in creating the momentum to establish a globally recognized public health ‘brand’ as a target in the United Nations Sustainable Development Goals.
PB - Oxford University Press (OUP)
PY - 2021
SP - 169
EP - 175
T2 - Transactions of The Royal Society of Tropical Medicine and Hygiene
TI - The history of the neglected tropical disease movement
UR - https://academic.oup.com/trstmh/article-pdf/115/2/169/36129949/trab015.pdf
VL - 115
SN - 0035-9203, 1878-3503
ER -